Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.

3 Sep 2018

Scientists shed light on how dangerous inflammations are caused in the brain

The so-called CB1 receptor is responsible for the intoxicating effect of cannabis. However, it appears to act also as a kind of “sensor” with which neurons measure and control the activity of certain immune cells in the brain.

31 Aug 2018

Over past 20 years, the percentage of children with ADHD nearly doubles

The number of children diagnosed with attention deficit hyperactivity disorder (ADHD) has reached more than 10 percent, a significant increase during the past 20 years, according to a study released Friday.

31 Aug 2018

Brain exhibits similar changes in both ADHD and emotional instability disorders

In both ADHD and emotional instability disorders (eg borderline and antisocial personality disorder as well as conduct disorder in children), the brain exhibits similar changes in overlapping areas, meaning that the two types of conditions should be seen as related and attention should be paid to both during diagnosis.

31 Aug 2018

Almost half of total funding for publication of clinical trials is not disclosed, finds research

A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials that tested new cancer drugs.

31 Aug 2018

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

A $2 million phase 2 Small Business Technology Transfer grant to optimize a promising new compound that has shown efficacy in preclinical studies against treatment-resistant multiple myeloma has been awarded to a Medical University of South Carolina startup company, Leukogene Therapeutics, Inc., in collaboration with MUSC researcher and company founder, Nathan G. Dolloff, Ph.D. Dolloff is an assistant professor in the Department of Cell and Molecular Pharmacology & Experimental Therapeutics at MUSC and a member of MUSC Hollings Cancer Center.

31 Aug 2018

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Commercial antidepressants typically take two to four weeks to have a significant effect on a depressed patient. They are also inneffective in approximately 40% of the cases.

31 Aug 2018

Giving targeted social support activates brain regions involved in parental care

Providing "targeted" social support to other people in need activates regions of the brain involved in parental care- which may help researchers understand the positive health effects of social ties, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published in the Lippincott Portfolio by Wolters Kluwer.

30 Aug 2018

Stigmatizing views, false perceptions about psoriasis continue to persist among people in the U.S.

The stigma associated with the autoimmune disease psoriasis may lead people to avoid patients who show signs of the condition, including not wanting to date, shake hands, or have people in their homes if they suffer from the disease.

30 Aug 2018

Component of cannabis could help in psychosis

Researchers from King’s College London have now found how the chemical cannabidiol or CBD from cannabis can reduce the abnormal brain activity in patients who are at risk of psychosis. The study was published in the latest issue of the journal JAMA Psychiatry.

30 Aug 2018

Ketamine’s role in treatment of depression: Study

The anaesthetic drug Ketamine has been shown to be beneficial in some cases of depression and suicidal ideation which have typically failed to respond to other standard antidepressant medications. A new study has explored the actual workings of ketamine in depression and found that the drug can act on the same receptors as opioid pain relievers.

30 Aug 2018

Risk factors for suicide attempts similar for soldiers regardless of prior mental health diagnosis

Regardless of whether or not they have had a prior mental health diagnosis, risk factors were still similar among soldiers who attempted suicide, according to a new JAMA Psychiatry study published Aug. 29. Researchers hope these findings will help continue to better understand risk factors in soldiers who have not been seen for a behavioral health diagnosis, and ultimately lead to identifying possible interventions.

30 Aug 2018

Both group and individual therapy can help children suffering from tics

Therapy against tics works, and both group and individual treatment are suitable methods to achieve a good effect.

29 Aug 2018

Wis. board will again cover state workers seeking transgender treatment

In a surprising reversal, a Wisconsin board has voted to again offer insurance coverage to transgender state employees seeking hormone therapy and gender confirmation surgery.

29 Aug 2018

Ketamine's acute antidepressant effect requires opioid system activation, finds study

A new study appearing online today from the American Journal of Psychiatry finds that ketamine's acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary for any antidepressant's mechanism of action.

29 Aug 2018

Study explores whether chemotherapy affects older woman's ability to function

Older women are at higher risk for developing breast cancer than younger women are--almost half of all breast cancer cases, and most breast cancer deaths, occur in women who are 65 or older. Despite this, we know very little about how breast cancer and its treatments affect older women.

29 Aug 2018

New parental training program improves toddlers' reactions to mildly stressful situations

A parental training program for families referred to Child Protective Services improved toddlers' unconscious reactions to mildly stressful situations, as well as improving parents' behavior, according to a new study by researchers at the University of California, Davis and the University of Washington.

29 Aug 2018

MUSC and Siemens Healthineers join hands to advance quality of health care in South Carolina

The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.

28 Aug 2018

A late-life surprise: Taking care of frail, aging parents

"This won't go on for very long," Sharon Hall said to herself when she invited her elderly mother, who'd suffered several small strokes, to live with her.

23 Aug 2018

Common ADHD drug may cause adverse psychotic side effects

In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder and narcolepsy.

22 Aug 2018

Psychiatry News and Research

Further Reading

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Scientists shed light on how dangerous inflammations are caused in the brain

Over past 20 years, the percentage of children with ADHD nearly doubles

Brain exhibits similar changes in both ADHD and emotional instability disorders

Almost half of total funding for publication of clinical trials is not disclosed, finds research

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Giving targeted social support activates brain regions involved in parental care

Stigmatizing views, false perceptions about psoriasis continue to persist among people in the U.S.

Component of cannabis could help in psychosis

Ketamine’s role in treatment of depression: Study

Risk factors for suicide attempts similar for soldiers regardless of prior mental health diagnosis

Both group and individual therapy can help children suffering from tics

Wis. board will again cover state workers seeking transgender treatment

Ketamine's acute antidepressant effect requires opioid system activation, finds study

Study explores whether chemotherapy affects older woman's ability to function

New parental training program improves toddlers' reactions to mildly stressful situations

MUSC and Siemens Healthineers join hands to advance quality of health care in South Carolina

A late-life surprise: Taking care of frail, aging parents

Common ADHD drug may cause adverse psychotic side effects

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News